UNSPSC 85613505: Occlusion of accessory pancreatic duct, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of accessory pancreatic duct, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FLF8ZZ

UNSPSC 85613505 Occlusion of accessory pancreatic duct, via natural or artificial opening endoscopic is a Commodity code that does not align with recent state and local procurement activity. The code describes a specific medical procedure — endoscopic intervention on the pancreatic duct — yet the recent opportunities tagged to this code reflect entirely different scopes: independent disability medical evaluation services, surgical benefit carve-out programs, occupational health surveillance, specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve pancreatic duct occlusion or related procedural interventions.

The mismatch between the code's procedural scope and the actual work being solicited suggests either a tagging error in the source data or a classification misapplication. State and local governments do not appear to be actively procuring pancreatic duct occlusion services under this code. The recent opportunities show health plan administration, staffing, and occupational medicine work across Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington (Washington State Department of Transportation), Florida (Collier County), and Texas (Harris County), but no activity related to the endoscopic pancreatic procedure named in the code itself. Until the code is correctly matched with relevant solicitations or procurement activity realigns with the code's nominal scope, this code shows no actionable signal for vendors in the pancreatic intervention market.